SCHEMBL1965822

SCHEMBL1965822

Nc1cc(OCCF)c(C(=O)O)cc1N

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.39
HTR4 Q13639 1/20 0.39
ALDH1A1 P00352 7/20 0.38
KMT2A Q03164 3/20 0.38
S1PR3 Q99500 1/20 0.38
PTK2B Q14289 1/20 0.38
POLB P06746 2/20 0.37
HPGD P15428 2/20 0.37
GAA P10253 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
KDM4E B2RXH2 3/20 0.37
GLA P06280 1/20 0.37
KEAP1 Q14145 1/20 0.37
HSD17B10 Q99714 2/20 0.37
TSHR P16473 1/20 0.37
CDC25B P30305 1/20 0.36
CASP6 P55212 1/20 0.36
RCE1 Q9Y256 1/20 0.36
GFER P55789 1/20 0.35
RXFP1 Q9HBX9 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1968198 0.82 LMNA (0.42) ALDH1A1KMT2APOLBGAAKDM4E
SCHEMBL1972990 0.81 ALDH1A1 (0.40) ALDH1A1KMT2AS1PR3PTK2BPOLB
SCHEMBL1974546 0.79 KDM4E (0.44) ALDH1A1GAAKDM4EPKMTDP1
SCHEMBL11232189 0.79 TSHR (0.59) ALDH1A1KMT2APOLBHPGDGAA
SCHEMBL1965983 0.78 ALDH1A1 (0.53) ALDH1A1KMT2APOLBHPGDL3MBTL1
SCHEMBL670605 0.78 ALDH1A1 (0.36) ALDH1A1KMT2APOLBHPGDGAA
SCHEMBL13657517 0.75 PTPN11 (0.49) ALDH1A1S1PR3HPGDHSD17B10TSHR
SCHEMBL12466431 0.75 ALDH1A1 (0.47) ALDH1A1KMT2APTK2BKDM4EKEAP1
SCHEMBL20522110 0.75 PKM (0.47) ALDH1A1KMT2AS1PR3PTK2BGAA
SCHEMBL31497192 0.75 PKM (0.47) ALDH1A1KMT2AS1PR3PTK2BGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8916599-B2 1H-benz imidazole-5-carboxamides as anti-inflammatory agents OREXO AB (SE) 2014-12-23 US disclosed
US-20110312935-A1 1H-Benz Imidazole-5-Carboxamides As Anti-Inflammatory Agents BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-12-22 US disclosed
EP-2334652-A1 1H-BENZ IMIDAZOLE-5-CARBOXAMIDES AS ANTI-INFLAMMATORY AGENTS Boehringer Ingelheim International GmbH (DE) 2011-06-22 EP disclosed
WO-2010034796-A1 1H-BENZ IMIDAZOLE-5-CARBOXAMIDES AS ANTI-INFLAMMATORY AGENTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-04-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110312935-A1 1H-Benz Imidazole-5-Carboxamides As Anti-Inflammatory Agents MAPRE2, MAPRE1, H1-4 ACHE 1938/4885HTR4 1476/4885ALDH1A1 1202/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.